Acyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent Individuals. [electronic resource]
- PloS one 2015
- e0125287 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't